Abstract Objective To explore the correlation between the glucocorticoid receptor gene (NR3C1) rs7701443 and rs2963156 polymorphisms and cerebral small vessel disease (CSVD). Methods Using the first-generation sequencing method, patients from the outpatient and inpatient of the Emergency General Hospital from March 2013 to May 2018 were selected and divided into the CSVD group (200 patients) and the control group (100 patients) based on the presence or absence of CSVD diagnosed by cranial MRI. The distribution of NR3C1 rs7701443 and rs2963156 polymorphisms were analyzed. Results There was no statistically significant difference in the frequency of rs7701443 between the two groups (P ＞ 0.05); after excluding the influence of CSVD risk factors such as hypertension, coronary heart disease and diabetes, the difference in the frequency of genotypes between the two groups was not statistically significant (P ＞ 0.05). There was no statistically significant difference in the frequency of rs2963156 between the two groups (P ＞ 0.05); after excluding the influence of CSVD risk factors such as hypertension, coronary heart disease, diabetes, etc., the difference in the frequency of genotypes between the two groups was not statistically significant (P ＞ 0.05). Conclusion The polymorphisms of rs7701443 and rs2963156 of NR3C1 may not be related to the onset of CSVD.
LI Jingya1,2 WANG Jun1 MO Weiyan1 REN Xin1 WANG Qi1 ZHOU Weidong1. Correlation analysis between glucocorticoid receptor gene NR3C1 rs7701443, rs2963156 polymorphisms and cerebral small vessel disease[J]. 中国医药导报, 2021, 18(16): 42-45.
[1] Traylor M，Rutten-Jacobs LC，Thijs V，et al. Genetic Associations With White Matter Hyperintensities Confer Risk of Lacunar Stroke [J]. Stroke，2016，47（5）：1174-1179.
[2] van Rossum EF，de Jong FJ，Koper JW，et al. Glucocorticoid receptor variant and risk of dementia and white matter lesions [J]. Neurobiol Aging，2008，29（5）：716-723.
[3] Yan YX，Dong J，Zhang J，et al. Polymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population [J]. Endocrine，2014，47（3）：740-748.
[4] 刘承浩，孙丽伟，周卫东.脑小血管病的候选基因研究进展[J].中国神经免疫学和神经病学杂志，2016，23（4）：293-297.
[5] 中华医学会神经病学分会，中华医学会神经病学分会离血管病学组.中国脑小血管病诊治共识[J].中华神经科杂志，2015，48（10）：838-844.
[6] 孙丽伟，周卫东，刘承浩，等.脑白质病变患者认知功能的前瞻性研究[J].中国卒中杂志，2016，11（3）：196-201.
[7] Feng C，Bai X，Xu Y，et al. Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease [J]. Int J Med Sci，2013，10（4）：408-412.
[8] Liu J，Rutten-Jacobs L，Liu M，et al. Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease： A Mendelian Randomization Analysis [J]. Stroke，2018，49（6）：1325-1331.
[9] Kraft P，Schuhmann MK，Garz C，et al. Hypercholesterolemia induced cerebral small vessel disease [J]. PLoS One，2017，12（8）：e0182822.
[10] Liu Y，Dong YH，Lyu PY，et al. Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment [J]. Chin Med J （Engl），2018，131（5）：615-619.
[11] Li W，Hu B，Li GL，Zhao XQ，et al. Heterozygote genotypes at rs2222823 and rs2811712 SNP loci are associated with cerebral small vessel disease in Han Chinese population [J]. CNS Neurosci Ther，2012，18（7）：558-565.
[12] Zhang C，Chen Q，Wang Y，et al，Chinese Intra Cranial Athero Sclerosis （CICAS） Study Group. Risk factors of dilated Virchow-Robin spaces are different in various brain regions [J]. PLoS One，2014，9（8）：e105505.
[13] Zhang AJ，Yu XJ，Wang M. The clinical manifestations and pathophysiology of cerebral small vessel disease [J]. Neurosci Bull，2010，26（3）：257-264.
[14] Mestre H，Kostrikov S，Mehta RI，et al. Perivascular spaces，glymphatic dysfunction，and small vessel disease [J]. Clin Sci （Lond），2017，131（17）：2257-2274.
[15] Juszczak GR，Stankiewicz AM. Glucocorticoids，genes and brain function [J]. Prog Neuropsychopharmacol Biol Psychiatry，2018，82：136-168.
[16] Tao HM，Chen GZ，Lu XD，et al. TGF-beta 1 Codon 10 polymorphism is associated with cerebral SVD [J]. Neurol 2011，38（6）：869-873.
[17] Shan XY，Chen GZ，Cheng GP，et al. Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese [J]. J Mol Neurosci，2013， 51（2）：461-466.
[18] 闫宇翔，董晶，刘佑琴，等.NR3C1基因多态性与心血管疾病危险因素相关性[J].中国公共卫生，2015，31（4）：385-389.
[19] Wardlaw JM，Smith C，Dichgans M. Mechanisms of sporadic cerebral small vessel disease：insights from neuroimaging [J]. Lancet Neurol，2013，12（5）：483-497.
[20] Brown WR，Thore CR. Review：cerebral microvascular pathology in ageing and neurodegeneration [J]. Neuropathol Appl Neurobiol，2011，37（1）：56-74.
[21] Dumas A，Dierksen GA，Gurol ME，et al. Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy [J]. Ann Neurol，2012，72（1）：76-81.
[22] Zhang J，Liu Z，Li Z，et al. Disrupted White Matter Network and Cognitive Decline in Type 2 Diabetes Patients [J]. J Alzheimers Dis，2016，53（1）：185-195.
[23] Tan R，Traylor M，Rutten-Jacobs L，et al. New insights into mechanisms of small vessel disease stroke from genetics [J]. Clin Sci （Lond），2017，131（7）：515-531.
[24] Santen RJ，Jewell CM，Yue W，et al. Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids [J]. J Clin Endocrinol Metab，2018，103（10）：3630-3639.
[25] Nezu T，Hosomi N，Aoki S，et al. Endothelial dysfunction is associated with the severity of cerebral small vessel disease [J]. Hypertens Res，2015，38（4）：291-297.
